Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Teva Pharmaceutical Industries Ltd. (TEVA) had Receiveable Turnover of 5.41 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$16.54B |
|
$-1.64B |
|
$8.48B |
|
$8.06B |
|
$16.85B |
|
$-303.00M |
|
$-981.00M |
|
$-1.28B |
|
$-1.28B |
|
$-1.96B |
|
$-1.96B |
|
$-1.96B |
|
$-1.96B |
|
$-303.00M |
|
$756.00M |
|
1.13B |
|
1.13B |
|
$-1.45 |
|
$-1.45 |
|
| Balance Sheet Financials | |
$12.55B |
|
$4.58B |
|
$26.77B |
|
$39.33B |
|
$12.80B |
|
$16.00B |
|
$21.15B |
|
$33.95B |
|
$5.38B |
|
$-14.19B |
|
$5.38B |
|
1.13B |
|
| Cash Flow Statement Financials | |
$1.25B |
|
$792.00M |
|
$-1.79B |
|
$3.23B |
|
$3.30B |
|
$73.00M |
|
$123.00M |
|
$-78.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.98 |
|
-- |
|
-- |
|
0.75 |
|
3.31 |
|
48.74% |
|
-1.83% |
|
-1.83% |
|
4.57% |
|
-7.76% |
|
-9.91% |
|
$792.00M |
|
-- |
|
-- |
|
-- |
|
0.42 |
|
2.82 |
|
|
Receiveable Turnover |
5.41 |
67.49 |
|
-36.41% |
|
13.81% |
|
-4.98% |
|
-9.16% |
|
$4.75 |
|
$0.70 |
|
$1.10 |
|